VisionClearBlue Eye Clinic Business Plan — The Hub-and-Spoke Network & Clinic Economics

The economic engine of VisionClearBlue is the clinic rollout: opening nine equipment-intensive flagship clinics in phases, and ramping each to maturity as its patient base, referral network and surgical throughput build. This section sets out the network footprint, the rollout-and-ramp that drives the J-curve, the unit economics of a mature clinic, the staffing model and its binding specialist constraint, and the operating assumptions used throughout the financial model. Consistent with the Important Notice, clinic revenue, volume and margin figures are planning assumptions built to be consistent with the sponsor’s stated Year-5 targets and benchmarked to South African eye-care economics.

The rollout-and-ramp — a healthcare J-curve

A clinic network is a rollout business. Each flagship must be built, equipped and staffed, roughly R50 million and a full clinical team, before it can treat patients at scale, and each then ramps over about three years as referrals, medical-aid relationships and surgical volumes build. VisionClearBlue plans to open three metro clinics in Year 1, three secondary-city clinics in Year 2, and the remaining three in Year 3. Because each clinic carries a heavy fixed cost from opening while its revenue ramps, the network EBITDA is thin or negative early and climbs into the 20–25% target band only as the clinics mature.

Figure 7. *Clinic rollout and network maturity — the ramp*

Key findingNetwork maturity — not clinic count — is the value driver

It is tempting to track progress by clinics opened, but the economics are driven by network maturity: how full and how productive each clinic is. Three newly opened clinics all in their first ramp year (Year 1) produce a negative network EBITDA; the same three at maturity are strongly profitable. Revenue per open clinic rises from roughly R54 million in the opening year toward the R135 million mature flagship run-rate. The plan’s success therefore depends less on opening nine clinics — which is largely a construction-and-capital task, and more on filling and staffing them, which is the harder, longer and more uncertain part.

The nine-province footprint

One flagship clinic anchors each province. The three metros carry the highest volumes and open first; the six remaining provincial flagships extend specialist access to markets where private ophthalmology is scarce or absent. Satellite clinics in secondary cities can be added later off each hub.

Figure 8. *Nine provincial flagship clinics — phased rollout*

Phase	Provinces (flagship city)	Timing
Phase 1 — metros	Gauteng (Johannesburg), Western Cape (Cape Town), KwaZulu-Natal (Durban)	Year 1
Phase 2 — secondary	Eastern Cape (Gqeberha), Free State (Bloemfontein), Limpopo (Polokwane)	Year 2
Phase 3 — remaining	Mpumalanga (Mbombela), North West (Rustenburg), Northern Cape (Kimberley)	Year 3

Unit economics of a mature flagship clinic

A mature flagship is planned to generate roughly R135 million of revenue a year across surgery, consultations, optical and screening. This is an ambitious, high-throughput run-rate: it implies a very busy multi-doctor surgical centre. The table sets out the indicative mature-clinic economics that underpin the network model.

Metric	Mature flagship	Basis
Revenue per clinic	~R135m/year	Blended across all service lines
Consultations	~20,000/year	~80 per working day
Surgeries	~2,200/year	Cataract, laser, retina, glaucoma
Optical sales	~11,000/year	On-site dispensing & laboratory
Staff	~24 per clinic	2 ophthalmologists, 2 optometrists + team
Clinic-level EBITDA margin	~28–30%	Before head-office allocation
Capital cost	R50m	Equipment-heavy build

The staffing model and the specialist constraint

Each clinic is staffed by approximately 24 people: two ophthalmologists, two optometrists, a practice manager, six ophthalmic nurses, six optical assistants, two receptionists, a finance officer, a marketing officer and two cleaners, supported by a visiting anaesthetist and theatre staff. Across nine clinics and head office, the network employs over 300 people. But the number that matters is eighteen, the ophthalmologists, because they are the scarce, binding input.

Figure 9. *Employment at scale — around 300 staff nationwide*

Analyst flagRecruiting and retaining eighteen ophthalmologists is the single greatest risk

South Africa has only around 324 to 400 ophthalmologists in total, most of them in Gauteng, the Western Cape and KwaZulu-Natal. Staffing two per clinic across nine provinces, including Northern Cape, Limpopo, North West and Mpumalanga, where private ophthalmology is thin or absent, means competing for a scarce national resource and persuading specialists to practise outside the metros. Moreover, the 20,000-surgery target implies roughly 1,100 procedures per ophthalmologist a year, well above the 200–500 a typical private surgeon performs. The plan’s volume and revenue are therefore gated by specialist supply and surgical throughput far more than by capital. Mitigation, competitive packages and equity participation, visiting-surgeon rosters, optometrist and nurse task-sharing, tele-ophthalmology, AI triage and high-throughput theatre design, is central, not optional, and even so the metro clinics will ramp faster and more reliably than the rural ones.

Clinical volumes and the throughput challenge

The network targets 180,000 consultations, 20,000 surgeries and 100,000 optical sales a year at maturity. These volumes ramp with clinic openings and maturation. The surgical target is the most demanding: achieving 20,000 procedures requires high-throughput theatres, efficient patient flow, visiting-surgeon capacity and disciplined scheduling. Cataract surgery output in South Africa is well documented to be constrained by surgeon availability rather than demand, so the model’s throughput assumptions, and the staffing to deliver them, are the operational crux.

Figure 10. *Clinical volume ramp — toward 180,000 consultations and 20,000 surgeries*

How the network revenue builds

The network revenue is the sum of three clinic cohorts at different stages of maturity in any given year. The table shows how revenue builds as each cohort ramps, the metros (opened Year 1) maturing first, the secondary cities (Year 2) following, and the final provinces (Year 3) still ramping at the end of the plan.

	Year 1	Year 2	Year 3	Year 4	Year 5
Clinics open	3	6	9	9	9
Network maturity	13%	37%	71%	91%	100%
Revenue (R m)	162	454	859	1,102	1,215
Revenue per open clinic (R m)	54	76	95	122	135

Figure 11. *Average revenue per open clinic — rising as clinics mature*

Working capital and medical-aid receivables

A clinic network’s working capital is dominated by medical-aid receivables: a substantial share of revenue is reimbursed by medical schemes on 30–60 day terms, against which the clinics carry consumables and optical inventory. The model sets net working capital at about 9% of revenue. Efficient medical-aid claims administration, pre-authorisation and collections are operationally critical, slow or disputed reimbursement is the most common cash-flow risk in private healthcare, and a dedicated revenue-cycle function is built into the head-office model.